USFDA approves Pfizer vaccine for ages 12-15

The US Food and Drug Administration has approved the Pfizer vaccine against the coronavirus for emergency use for children ages 12 to 15. Monday’s approval means that middle school students could be vaccinated in time for the opening of schools in the fall. The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will hold an emergency meeting on Wednesday to discuss whether to recommend the shot for 12- to 15-year-olds. A vote is scheduled to tale place following the meeting. Shots could be offered as soon as CDC adopts the FDA recommendation.